Skip to content
Open access

Serial Changes in CSF Volume Proportion on Brain CT and 6-Month Neurologic Outcomes After Cardiac Arrest: A 72–96-h Landmark Cohort Study

Sep 2026 · Journal of Clinical Medicine · Vol 15 · 0 citations · 23 references
Medicine

Abstract

Background: Single-time-point cerebrospinal fluid (CSF) volume proportion (pCSFV) has shown limited prognostic utility after out-of-hospital cardiac arrest (OHCA). We hypothesized that serial within-patient change in pCSFV (ΔpCSFV), rather than absolute values, would reflect progression of neurologic injury. Methods: This retrospective 72–96-h landmark cohort study included comatose adult OHCA survivors who underwent brain computed tomography (CT) within 6 h (early) and at 72–96 h (delayed) after return of spontaneous circulation. pCSFV was quantified using Hounsfield-unit-based volumetry. ΔpCSFV was calculated as delayed pCSFV minus early pCSFV. The primary outcome was poor 6-month neurologic outcome (Cerebral Performance Category 3–5). Results: Among 125 patients, 63 (50.4%) had poor neurologic outcomes. Early and delayed pCSFV did not differ significantly between outcome groups, whereas ΔpCSFV was lower in the poor-outcome group (p < 0.001). In the five-parameter multiple-imputation model, ΔpCSFV was associated with poor outcome (adjusted odds ratio [aOR] 0.684 per 1 percentage-point increase, 95% confidence interval [CI] 0.494–0.947; p = 0.022), with a consistent result in the complete-case sensitivity analysis (aOR 0.648, 95% CI 0.446–0.940; p = 0.022). However, this association was attenuated after additional adjustment for early pCSFV (aOR 0.728, 95% CI 0.462–1.146; p = 0.170). Adding ΔpCSFV to the baseline model did not significantly improve discrimination (area under the curve 0.962 vs. 0.955; p = 0.292). Conclusions: ΔpCSFV may provide complementary information on serial CSF-space changes but should not be interpreted as a baseline-independent marker. These findings apply only to patients who survived and underwent delayed CT at 72–96 h. The observed data-derived cutoff is exploratory and requires external validation before any clinical application.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.